Pharmafile Logo

Glaucoma in perspective

- PMLiVE

Iontas gets UK backing for chronic pain antibody project

Receives just under £800,000 from the UK government

- PMLiVE

J&J moves quickly ahead with trials of myeloma CAR-T

Expects to start trials during the second half of this year

Abeona Therapeutics appoints new additions to board of directors

Stefano Buono and Richard Van Duyne join the biopharma

- PMLiVE

Prevail Therapeutics adds to its board of directors

Francois Nader joins the biotech

The true potential of mobile health tech

Are patients willing to adopt digital?

- PMLiVE

Patient outcomes in practice: delivering value that transforms lives

Over the next five years, the NHS needs to drive efficiencies of £22bn. Like all global healthcare systems, it faces the challenge of improving the health of larger and older...

EphMRA Annual Conference 2018

Visit us on stand number 20

Inizio

Connected Patients – Adopting a patient-centric approach in emerging markets

The concept of patient centricity and putting the patient at the heart of care is being widely adopted by the healthcare industry – the general consensus being that it’s going...

Inizio

Combination therapies in oncology: The benefits of integrated insights

14 June 2018 11am EDT | 8am PDT | 4pm BST | 5pm CE

Inizio

Intellus round up 2018

Earlier this month, US President Harriet Kozak and Emerging Markets Director Rachel Howard attended the inaugural Intellus Worldwide Summit in Philadelphia

Inizio

Janssen & Research Partnership win prestigious BHBIA Best Business Impact award

We are delighted to announce that Janssen and Research Partnership have won the BOBI (Best of Business Intelligence) Award in the Best Business Impact category at the BHBIA annual conference in London for our collaborative market research...

Inizio

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links